Lombard Odier Asset Management (USA)’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,998
Closed -$219K 270
2024
Q2
$219K Sell
10,998
-22,600
-67% -$440K 0.02% 234
2024
Q1
$669K Sell
33,598
-6,362
-16% -$123K 0.02% 214
2023
Q4
$896K Buy
+39,960
New +$825K 0.02% 210

Other funds holding AVNS

Lombard Odier Asset Management (USA)'s AVNS Position: Q3 2024 in Review

Lombard Odier Asset Management (USA) sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 10,998 shares — an estimated $219K sold.

Lombard Odier Asset Management (USA) first reported a position in AVNS in Q4 2023 and held it in 3 quarters. The position peaked at $896K in Q4 2023. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

  • Lombard Odier Asset Management (USA) reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 10,998 Avanos Medical shares in Q3 2024, an estimated $219K.
  • Lombard Odier Asset Management (USA) first reported a position in Avanos Medical in Q4 2023 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s Avanos Medical position peaked at $896K in Q4 2023.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2024, filed 14 Nov 2024.